Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA570303
Title Escape from Tumor Cell Dormancy.
Publication Date Oct 2012
Media Count 8p
Personal Author A. Wells L. Griffith
Abstract An insiduously terrifying aspect of breast cancer is its propensity to recur in metastatic sites even over a decade after all evidence of cancer has passed. It is obvious that these cells had escaped very early from the primary tumor as this occurs even in small, node-negative and in situ primary lesions, and that these micrometastases survival chemotherapeutic regimens that shrink and extirpate the primary carcinomas. Thus this mortal turn of events leads to three key questions how do the cells escape early, how do they survive over extended periods, and what causes these dormant lesions to become aggressive at these late dates. The area of metastatic dissemination of primary cells has received a great level of inspection with an understanding of underlying molecular mechanisms, even if we do not yet have therapies. While chemotherapy survival in ectopic sites has been studies more recently, this is usually done in the context of a growing lesion. The truly under-appreciated and under-studied aspect is the last, that of re-emergence from dormancy. Understanding what triggers dormant breast cancer cells to emerge and form frank and mortal metastases would allow the development not only of rationale therapeutics but of prevention and possibly lifestyle avoidance. Herein, these issues are addressed using a novel organotypic bioreactor in which tumor cells can be followed for weeks to months, the process of seeding, dormancy and emergence can be followed.
Keywords Biochemistry
Breast cancer
Escape systems

Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
Corporate Author Massachusetts Inst. of Tech., Cambridge.
Document Type Technical report
Title Note Final rept. 22 Sep 2010-21 Sep 2012.
NTIS Issue Number 1314
Contract Number W81XWH-10-1-1013

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader